Atrial fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Globally, the atrial fibrillation has been increasing over the past few years. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures. Global Atrial Fibrillation Surgery Market is expected to grow at a CAGR between 14.0% and 14.5% over the Forecast period 2016 to 2022. Atrial Fibrillation Surgery Market is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Globally, the atrial fibrillation has been increasing over the past few years. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures. The Global Atrial Fibrillation Surgery market is expected to be primarily driven by Factors such as Rising geriatric population worldwide, and Favorable results exhibited by clinical trials aimed at treating atrial fibrillation and Rising prevalence of disorders. However, the growth in the global atrial fibrillation surgery market is likely to be restrained by factors such as Stringent product approval regulations by agencies such as FDA, CE and European Medicines Agency. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures.Segments Covered The Atrial Fibrillation Surgery Market is segmented on the basis of Product, Procedures. On the basis of surgical procedures the market is segmented as catheter ablation and surgical ablation. Furthermore, on the basis of products the market is segmented as Geographic Coverage The regions covered in the report include North America, Europe, Asia-Pacific, and Rest of the World .North America region covers the country markets such as U.S., Canada, and Mexico. Furthermore Europe includes the country markets such as Germany, U.K., France, Spain, and Rest of Europe. The Asia-Pacific region covers the analysis of countries such as China Japan India Australia/New Zealand and Rest of APAC. Among the geographies North America is expected to be the largest market for Atrial Fibrillation Surgery Market over the Forecast period 2016 to 2022. Furthermore Asia-Pacific is expected to grow at the highest CAGR over the forecast period. Companies Covered • Biosense Webster,Inc. • Medtronic, Inc. • St. Jude Medical, Inc. • Boston Scientific Corporation • Atricure, Inc. • Cardiofocus, Inc. • Ncontact, Inc. • Carima, Inc. • Biotroik Se & Co.Kg,
1. Report Overview 1.1 Report Description 1.2 Research Methods 1.3 Research Approaches 2. Executive Summary 3. Atrial Fibrillation Surgery Market Overview
